Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Neomed Institute

Headquarters: Montreal, QC, Canada
Year Founded: 2012
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Apr 18, 2023
Deals

Bellus’ focus on cough program pays off with $2B GSK buyout

Montreal biotech shed other programs, drove single asset through mid-stage trials to provoke takeout interest
BioCentury | Feb 8, 2020
Emerging Company Profile

Serentrix: pain relief without side effects

Serentrix is looking to improve upon an old target for pain
BioCentury | Jan 23, 2019
Distillery Therapeutics

Neurology

BioCentury | Dec 15, 2017
Financial News

Bellus Health raises C$20M in follow-on

BioCentury | Dec 15, 2016
Company News

Management tracks

BioCentury | Feb 16, 2015
Company News

Neomed Institute, GlaxoSmithKline deal

BioCentury | Sep 22, 2014
Company News

Neomed Institute pharmaceuticals news

BioCentury | Apr 17, 2014
Strategy

Expanding into new (bromo)domains

BioCentury | Apr 7, 2014
Company News

Epigenetix, Neomed Institute deal

BioCentury | Jan 30, 2014
Translation in Brief

Translational tidbits

Items per page:
1 - 10 of 16